Atlas Trials

ORIC Pharmaceuticals

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch ORIC Pharmaceuticals

RecordFirmDate
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1) (NCT07723248)ORIC Pharmaceuticals2026-07-01
ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC (NCT06816992)ORIC Pharmaceuticals2025-02-27
Effect of Food on the Pharmacokinetics of ORIC-114 (NCT06012721)ORIC Pharmaceuticals2023-09-11
Study of ORIC-944 in Patients With Metastatic Prostate Cancer (NCT05413421)ORIC Pharmaceuticals2022-06-01
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration (NCT05315700)ORIC Pharmaceuticals2022-03-10
Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma (NCT05227144)ORIC Pharmaceuticals2022-01-06
Study of ORIC-101 in Combination With Enzalutamide (NCT04033328)ORIC Pharmaceuticals2019-10-28
Study of ORIC-101 in Combination With Anticancer Therapy (NCT03928314)ORIC Pharmaceuticals2019-05-02
Single and Multiple Dose Study of ORIC-101 in Adult Healthy Subjects (NCT03835637)ORIC Pharmaceuticals2018-03-23
Study of ORIC-101 in Healthy Adult Subjects (NCT03324555)ORIC Pharmaceuticals2017-10-19

Track ORIC Pharmaceuticals automatically

Every clearance here is in the API, with alerts when new ones post.